Showing results (521-530 of 1,080) with videos related to
Sort By:
Pageof 108
Cancer Letters|February 6, 2007
Survivin: a promising tumor biomarkerMichael J Duffy, Norma O'Donovan, Donal J Brennan, et al.American Journal of Veterinary Research|October 24, 2019
Effect of bite distance of an epitendinous suture from the repair site on the tensile strength of canine tendon constructsDaniel J Duffy, Christina J Cocca, Mariana E Kersh, et al.Transgenic Research|November 1, 1996
FLP-mediated site-specific recombination in microinjected murine zygotesD L Ludwig, J R Stringer, D C Wight, et al.Conservation Biology : the Journal of the Society for Conservation Biology|September 19, 2008
Inferring national and regional declines of rare orchid species with probabilistic modelsKarl J Duffy, Naomi E Kingston, Brendan A Sayers, et al.Veterinary Surgery : VS|April 2, 2021
Influence of normograde versus retrograde catheterization of bile ducts in dogs treated for gallbladder mucoceleAllison B Putterman, Laura E Selmic, Cameron Kindra, et al.Cancer|October 15, 1994
Urokinase plasminogen activator as a prognostic marker in different subgroups of patients with breast cancerM J Duffy, D Reilly, E McDermott, et al.Aerospace Medicine and Human Performance|July 11, 2025
Measuring Pilot Physiology During In-Flight Training and Implications for Real-Time MonitoringXiaomin Yue, Kevin Andres, Michelle J Duffy, et al.Cancer|August 1, 1988
Urokinase-plasminogen activator, a marker for aggressive breast carcinomas. Preliminary reportM J Duffy, P O'Grady, D Devaney, et al.American Journal of Veterinary Research|May 25, 2021
Effect of epitendinous suture caliber on the tensile strength of repaired canine flexor tendonsDaniel J Duffy, Yi-Jen Chang, Matthew B Fisher, et al.Cancer Research|March 1, 1988
Tissue-type plasminogen activator, a new prognostic marker in breast cancerM J Duffy, P O'Grady, D Devaney, et al.Pageof 108